Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Mesothelioma and venous thrombosis

Mehlika Isildak, Gulay Sain Guven and Salih Emri
CMAJ July 06, 2004 171 (1) 11-11-a; DOI: https://doi.org/10.1503/cmaj.1040664
Mehlika Isildak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gulay Sain Guven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salih Emri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Ami Schattner and Natasha Kozack report a case of mesothelioma in a man who exhibited jugular and subclavian vein thrombosis.1 Malignant pleural mesothelioma is a relatively rare type of cancer that is reported to be associated with venous thromboembolism.2 We describe here a patient with malignant pleural and peritoneal mesothelioma who experienced portal vein thrombosis. This patient had a history of exposure to zeolite, and ascites developed while the patient was being followed for the malignant pleural mesothelioma.

CT of the abdomen revealed diaphragmatic invasion of the right pleural mesothelioma. In addition to the peritoneum, the omentum and mesentery were diffusely invaded by the tumour. At the same level, the portal vein and the inferior vena cava both appeared to have a lucent lumen and exhibited contrast enhancement at the vessel wall (Fig. 1).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Fig. 1: Transverse CT scan demonstrates thrombosis (arrows) of both the portal vein (VP) and the inferior vena cava (IVC).

Cancer patients are prone to thromboembolic events, either as part of a paraneoplastic syndrome or because of a decrease in anticoagulation factors, such as prothrombin C, prothrombin S and antithrombin III, caused by some chemotherapeutic agents.3 Mesothelioma cells and cell lines have been shown to secrete a pleiotropic cytokine, interleukin 6, which potentiates the production of platelets.4 In addition, mesothelioma cells release a sedimentable procoagulant material in vitro;5 however, the underlying mechanism of thrombosis in mesothelioma is still a mystery.

Physicians who care for patients with mesothelioma should keep in mind that the thrombotic complication of the disease is not rare and may also involve a relatively unusual site, the portal system.

Mehlika Isildak Gulay Sain Guven Department of Internal Medicine Salih Emri Department of Respiratory Medicine Hacettepe University Faculty of Medicine Ankara, Turkey

References

  1. 1.↵
    Schattner A, Kozack N. A 47-year-old man with mesothelioma and neck swelling. CMAJ 2004; 170(4):465.
    OpenUrlFREE Full Text
  2. 2.↵
    Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96:746-55.
    OpenUrlPubMed
  3. 3.↵
    Rogers JS 2nd, Murgo AJ, Fontana JA, Raich JC. Chemotherapy for breast cancer decreases plasma protein C and protein S.J Clin Oncol 1988; 6:276-81.
    OpenUrlAbstract
  4. 4.↵
    Nakano T, Chahinian AP, Shinjo M, Tonomura A, Miyake M, Togawa N, et al. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 1998;77:907-12.
    OpenUrlPubMed
  5. 5.↵
    Idell S, Pueblitz S, Emri S, Gungen Y, Gray L, Kumar A, et al. Regulation of fibrin deposition by malignant mesothelioma. Am J Pathol 1995; 147: 1318-29.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 171 (1)
CMAJ
Vol. 171, Issue 1
6 Jul 2004
  • Table of Contents
  • Index by author
  • Canadian Adverse Reaction Newsletter (93-100)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mesothelioma and venous thrombosis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mesothelioma and venous thrombosis
Mehlika Isildak, Gulay Sain Guven, Salih Emri
CMAJ Jul 2004, 171 (1) 11-11-a; DOI: 10.1503/cmaj.1040664

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Mesothelioma and venous thrombosis
Mehlika Isildak, Gulay Sain Guven, Salih Emri
CMAJ Jul 2004, 171 (1) 11-11-a; DOI: 10.1503/cmaj.1040664
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

Collections

  • Topics
    • Global health
    • Health care coverage

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire